Evidence map›Paper›PMID 27609304›Full record

ArticleScientific reports2016

Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides.

Pawel Bialk, Brett Sansbury, Natalia Rivera-Torres, Kevin Bloh, Dula Man, Eric B Kmiec

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. CRISPR/Cas9-mediated correction ofMolecular therapy. Nucleic acids · 2021
    Article
  8. Review
  9. Article
  10. Cas9 Mediated Correction ofOncoTargets and therapy · 2020
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pawel BialkGene Editing Institute, Helen F. Graham Cancer Center and Research Institute, Newark, Delaware, United States of America.
Brett SansburyGene Editing Institute, Helen F. Graham Cancer Center and Research Institute, Newark, Delaware, United States of America.
Natalia Rivera-TorresGene Editing Institute, Helen F. Graham Cancer Center and Research Institute, Newark, Delaware, United States of America.
Kevin BlohGene Editing Institute, Helen F. Graham Cancer Center and Research Institute, Newark, Delaware, United States of America.
Dula ManDepartment of Chemistry, Delaware State University, Dover, Delaware, United States of America.
Eric B KmiecGene Editing Institute, Helen F. Graham Cancer Center and Research Institute, Newark, Delaware, United States of America.

Funding

Predictive Modeling & Optimal Control Framework for Model-Based Epidemic Response in DelawareP20GM103446 · NIGMS · UNIVERSITY OF DELAWARE · PI MELINDA K DUNCAN · 2012 to 2026
$67.2M
The eye as a window into sickle cell disease morbidityP20GM109021 · NIGMS · NEMOURS CHILDREN'S HOSPITAL, DELAWARE · PI HILDENBRAND, AIMEE K · 2014 to 2025
$20.7M
NIGMS NIH HHS P20 GM103446NIGMS NIH HHS P20 GM109021
6 · The paper itself

Abstract

The repair of a point mutation can be facilitated by combined activity of a single-stranded oligonucleotide and a CRISPR/Cas9 system. While the mechanism of action of combinatorial gene editing remains to be elucidated, the regulatory circuitry of nucleotide exchange executed by oligonucleotides alone has been largely defined. The presence of the appropriate CRISPR/Cas9 system leads to an enhancement in the frequency of gene editing directed by single-stranded DNA oligonucleotides. While CRISPR/Cas9 executes double-stranded DNA cleavage efficiently, closure of the broken chromosomes is dynamic, as varying degrees of heterogeneity of the cleavage products appear to accompany the emergence of the corrected base pair. We provide a detailed analysis of allelic variance at and surrounding the target site. In one particular case, we report sequence alteration directed by a distinct member of the same gene family. Our data suggests that single-stranded DNA molecules may influence DNA junction heterogeneity created by CRISPR/Cas9.

Indexed as

AllelesBase Sequencebeta-GlobinsClone CellsCRISPR-Cas SystemsDNA RepairDNA, Single-StrandedGene EditingHCT116 CellsHumansK562 CellsPoint MutationTemplates, Geneticbeta-GlobinsDNA, Single-Stranded

Identifiers

PMID27609304
PMCPMC5016854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.